Os canabinoides estão ganhando força no espaço terapêutico, oferecendo benefícios potenciais que vão além de seus usos atualmente aprovados para epilepsia, esclerose múltipla e náusea induzida por quimioterapia. Pesquisas emergentes destacam sua promessa no controle da dor e no tratamento de distúrbios do sistema nervoso central relacionados ao estresse e à ansiedade. Este whitepaper explora o crescente corpo científico por trás dos medicamentos à base de canabinoides, orientando as partes interessadas sobre as complexidades do desenvolvimento de medicamentos nesse campo em rápida evolução, desde a seleção dos ingredientes ativos certos até o aumento da adesão do paciente.
Discover how dsm-firmenich and Bayer reduced vitamin C’s carbon footprint by 49% through renewable energy, process innovation, and sustainable pharma collaboration.
Discover how dsm-firmenich is tackling the challenge of bitter medicine with a receptor-based technology designed to elevate drug palatability and improve patient adherence.
Explore how dsm-firmenich can help pharma raise the bar in patient-centricity and sustainability.
Have an idea for a new project, a groundbreaking innovation, or a need for expert services? Let’s talk.
Don’t just take our word for it. Discover how our solutions can support your product development journey.
Customized blends of functional ingredients in one single, efficient premix.
Streamline your product development process and get to market faster.
From trade shows to conferences and other industry events, find out where you can meet us next.
Talking Nutrition, Health & Care
Explore new science, consumer insights, industry news and more in our latest articles.
Discover educational whitepapers, webinars, publications and technical information.
Request samples, place orders and view product documentation.